Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aagaard J, Vestergaard P (1990) Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord 18: 259–266
Ahlfors UG, Baastrup PC, Dencker SJ et al. (1981) Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatr Scand 64: 226237
American Psychiatric Association (1994) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry, 151 (suppl)
Angst J (1980) Verlauf unipolar depressiver, bipolar manisch-depressiver and schizo-affektiver Erkrankungen and Psychosen. Ergebnis einer prospektiven Studie. Fortschr Neurol Psychiatr 48: 3–30
Angst J (1981a) Ungeloste Probleme bei der Indikationsstellung zur Lithiumprophylaxe affektiver and schizoaffektiver Erkrankungen. Bibl Psychiatr 161: 34–44
Angst J (1981b) Clinical indications for a prophylactic treatment of depression. Adv Biol Psychiatr 7: 218–229
Angst J, Weis P, Grof P, Baastrup C, Schou M (1970) Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry 116: 604–614
Baastrup PC (1964) The use of lithium in manic-depressive psychosis. Compr Psychiatry 5: 396–408
Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 2: 326–330
Baastrup PC, Schou M (1967) Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 16: 162–172
Berghöfer A, Kossmann B, Miiller-Oerlinghausen B (1996) Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years. Acta Psychiatr Scand 93: 349–354
Berghöfer A, Müller-Oerlinghausen B (1996) No loss of efficacy after discontinuation and reinstitution of long-term lithium treatment? In: Gallicchio VS, Birch NJ (eds) Lithium: biochemical and clinical advances. Weidner Publishing Group, Cheshire, 39–46
Blackwell B, Shepherd M (1968) Prophylactic lithium: another therapeutic myth? Lancet 1: 968–971
Bouman TK, de Vries J, Koopmans IH (1992) Lithium prophylaxis and interepisode mood. A prospective longitudinal comparison of euthymic bipolars and non-patient controls. J Affect Disord 24: 199–206
Bunney WE (1978) Psychopharmacology of the switch process in affective illness. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven, New York, pp. 1249–1259
Cade JFJ (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 36: 349–352
Calabrese JR, Wayshville MJ (1995) Lithium therapy: limitations and alternatives in the treatment of bipolar disorders. Ann Clin Psychiatry 7: 103–112
Carroll BJ (1979) Prediction of treatment outcome with lithium. Arch Gen Psychiatry 36: 870–878
Coppen A, Ghose K, Montgomery S, Rama Rao VA, Bailey J, Jorgensen A (1978a) Con-tinuation therapy with amitriptyline in depression. Br J Psychiatry 133: 28–33
Coppen A, Ghose K, Rao R, Bailey J, Peet M (1978b) Mianserin and lithium in the prophylaxis of depression. Br J Psychiatry 133: 206–210
Coppen A, Montgomery SA, Gupta RK, Bailey JE (1976) A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Br J Psychiatry 128: 479–485
Coppen A, Noguera R, Bailey J et al. (1971) Prophylactic lithium in affective disorders. Lancet 2: 275–279
Coryell W, Endicott J, Maser JD, Mueller T, Lavori P, Keller M (1995) The likelihood of recurrence in bipolar affective disorder: the importance of episode recency. J Affect Disord 33: 201–206
Cundall RL, Brooks PW, Murray LG (1972) A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 2: 308–311
Dang T (1995) Die Langzeittherapie and Rezidivprophylaxe mit Lithium, Carbamazepin oder Antidepressiva bei Patienten mit affektiven and schizoaffektiven Erkrankungen: eine Metaanalyse. Dissertation, Ludwig-Maximilians-Universitat, Munchen Dardennes R, Even C, Bange F, Heim, A (1995) Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorder. Br J Psychiatry 166: 378–381
Davis JM (1976) Overview: Maintenance therapy in psychiatry: II. Affective disorders. Am J Psychiatry 133: 1–13
Dickson WE, Kendell RE (1986) Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychol Med 16: 521–530
Dunner DL, Stallone F, Fieve RR (1976) Lithium carbonate and affective disorders V. A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry 33: 117–120
Editorial (1969) Lithium. Lancet 1: 709–710
Felber W (1981) Rezidivprophylaxe affektiver Erkrankungen mit Lithium and ihre Auswirkungen. Psychiatria Clin 14: 161–166
Felber W (1993) Rezidivprophylaxe affektiver Erkrankungen mit Lithium. Multicenter-Studie Lithiumtherapie bei 850 Patienten. Roderer, Regensburg
Felber W, Konig L, Lange E (1981) Rehabilitative Ziele in der Psychiatrie — Die Li-thiumbehandlung affektiver Psychosen. Dt Gesundh Wesen 36: 289–293
Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48: 851–855
Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321: 1489–1493
Gershon S, Soares JC (1997) Current therapeutic profile of lithium. Arch Gen Psychiatry 54: 16–20
Glen AIM, Johnson AL, Shepherd M (1984) Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial. Psychol Med 14: 37–50
Goodwin FK, Jamison KR (1990) Manic-depressive illness. Oxford University Press, New York
Greenhouse JB, Stangl D, Kupfer DJ, Prien RF (1991) Methodologic issues in maintenance therapy clinical trials. Arch Gen Psychiatry 48: 313–318
Greil W, Broucek B, Klein HE, Engel-Sittenfeld P (1982) Discontinuation of lithium maintenance therapy: Reversibility of clinical, psychological and neuroendocrinological changes. In: Emrich HM, Aldenhoff JB, Lux HD (eds) Basic mechanisms in the action of lithium. Excerpta Medica, Amsterdam, Oxford, Princeton, 235–248
Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1996a) Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. J Affect Disord 40: 179–190
Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oer-linghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling, T (1997a) Lithium versus carbamazepine in the maintenance treatment of schizoaffective dis-order: a randomised study. Eur Arch Psychiatr Neurol Sci 247: 42–50
Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1997b) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders–a randomized study. J Affect Disord 43: 151–161
Greil W, Ludwig-Mayerhofer W, Steller B, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1993) The recruitment process for a multicenter study on the long-term prophylactic treatment of affective disorders. J Affect Disord 28: 257–265
Greil W, Sassim N, Strobel-Sassim, C (1996b) Die manisch-depressive Krankheit: Therapie mit Carbamazepin. 2. Aufl., Thieme, Stuttgart, New York
Greil W, Sassim N, Strobel-Sassim, C (1996c) Manic depressive illness: therapy with carbamazepine. Thieme, Stuttgart, New York
Greil W, Schmidt S (1985) Medikamentose Rezidivverhutung von affektiven Psychosen. In: Hippius H, Greil W (Hrsg.) Psychiatrie fur die Praxis 2. Diagnostik and Therapie depressiver Storungen. MMV Medizin Verlag, München, 54–71
Greil W, Schmidt S (1988) Absetzsyndrome bei Antidepressiva, Neuroleptika and Li-thium. Munsch med Wschr 130: 704–707
Grof P, Hux M, Grof E, Arato M (1983) Prediction of response to stabilizing lithium treatment. Pharmacopsychiatria 16: 195–200
Guscott R, Taylor L (1994) Lithium prophylaxis in recurrent affective illness. Br J Psychiatry 164: 741–746
Haag M, Haag H, Eisenried F, Greil W (1984) RBC-choline: changes by lithium and re-lation to prophylactic response. Acta Psychiatr Scand 70: 389–399
Harrow M, Goldberg JF, Grossman LS, Meltzer HY (1990) Outcome in manic disorders. Arch Gen Psychiatry 47: 665–671
Hartigan GP (1963) The use of lithium salts in affective disorders. Br J Psychiatry 109: 810–814
Hullin RP, McDonald R, Allsopp MNE (1972) Prophylactic lithium in recurrent affective disorders. Lancet 1: 1044–1046
Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A (1982) Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. A prospektive, placebo-controlled comparison. Arch Gen Psychiatry 39: 1065–1069
Kasper S, Kaspar A (1994) Langzeitbehandlung affektiver Storungen. Nervenarzt 65: 577–589
Klein F, Gittelman R, Quitkin F, Riskin A (1980) Diagnosis and treatment of psychiatric disorders. 2nd edition, Williams u. Wilkins, Baltimore, London
Klein HE, Broucek B, Greil W (1981) Lithium withdrawal triggers psychotic states. Br J Psychiatry 139: 255–256
Kraepelin E (Hrsg.) (1909) Allgemeine Psychiatrie. Barth, Leipzig
Koukopoulos A, Reginaldi D (1980) Recurrences of manic-depressive episodes during lithium treatment. In: Johnson FN (ed) Handbook of lithium therapy. MTP Press, Lancaster, 109–117
Lewis JL, Winokur G (1982) The induction of mania. Arch Gen Psychiatry 39: 303–306
Lundquist G (1945) Prognosis and course in manic-depressive psychoses. Acta Psychiatr Neurol (suppl) 35: 1–96
Maj M, Pirozzi R, Kemali D (1989) Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacol 98: 535–538
Maj M, Pirozzi R, Magliano L (1995) Nonresponse to reinstituted lithium prophylaxis in prevoiusly responsive bipolar patients: prevalence and predictors. Am J Psychiatry 152: 1810–1811
Markar HR, Mander AJ (1989) Efficacy of lithium prophylaxis in clinical prophylaxis. Br J Psychiatry 155: 496–500
Melia PI (1970) Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 116: 621–624
Mindham RHS, Howland C, Shepherd M (1973) An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 3: 5–17
Moncrieff J (1995) Lithium revisited: a re-examination of the placebo-controlled trials of lithium prophylaxis in manic depressive disorder. Br J Psychiatry 167: 569–574
Müller-Oerlinghausen B (1977) 10 Jahre Lithium-Katamnese. Nervenarzt 48:483–493
Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R (1994) Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithiumtreated Patients. Acta Psychiatr Scand 90: 295–297
Noack CH, Trautner EM (1951) The lithium treatment of maniacal psychosis. Med J Aust 38: 219–222
O’Connell RA, Mayo JA, Flatow L, Cuthbertson B, O’Brien BE (1991) Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 159: 123–129
Perris C (1966) A study of bipolar (manic-depressive) and unipolar depressive psychoses. Acta Psychiatr Scand (suppl) 194: 1–88
Perris C (1968) The course of depressive psychoses. Acta Psychiatr Scand 44:238-248 Persson G (1972) Lithium prophylaxis in affective disorders. An open trial with matched controls. Acta Psychiatr Scand 48: 462–479
Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP (1994) Lithium prophylaxis of bipolar treatment: the value of combination treatment. Br J Psychiatry 164: 208–214
Pétursson H (1979) Prediction of lithium response. Compr Psychiatry 20: 226–241
Post RM, Leverich GS, Altshuler L, Mikalauskas K (1992) Lithium-discontinuation-induced refractoriness: preliminary observations. Am J Psychiatry 149: 1727–1729
Prien RF (1983) Long-term maintenance therapy in affective disorders. In: Rifkin A (ed) Schizophrenia and affective disorders. Wright, Boston, Bristol, London, 95–115
Prien RF, Caffey EM Jr, Klett J (1973a) Prophylactic efficacy of lithium carbonate in manic depressive illness. Arch Gen Psychiatry 28: 337–341
Prien RF, Klett J, Caffey EM Jr (1973b) Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 29: 420–425
Prien RF, Kocsis JH (1995) Long-term treatment of mood disorders In: Bloom F, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, 1067–1079
Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE (1984) Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry 41: 1096–1104
Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV (1981) Prophylactic lithium carbonate with and without imipramine for bipolar I patients. A doubleblind study. Arch Gen Psychiatry 38: 902–907
Sarantidis D, Waters B (1981) Predictors of lithium prophylaxis effectiveness. Prog Neuro Psychopharmacol 5: 507–510
Schou M (1978) Lithium for affective disorders: cost and benefit. In: Ayd FJ Jr, Taylor IJ (eds) Mood disorders: the world’s major public health problem. Ayd Medical, Baltimore, 117–137
Schou M (1993a) Lithium treatment of manic-depressive illness: a practical guide. 5th ed., S. Karger, New York
Schou M (1993b) Lithium Prophylaxis: about ‘Naturalistic’ or ‘Clinical Practice’ Studies. Lithium 4: 77–81
Schou M (1997) Lithium- Behandlung der manisch-depressiven Krankheit: Informationen fur Arzt, Patient and Angehorige. 4. Aufl., Thieme, Stuttgart, New York
Schou M, Juel-Nielsen N, Ströngren E, Voldby H (1954) The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 17: 250–260
Seagar CP, Bird RL (1962) Imipramine with electrical treatment in depression–a controlled trial. J Ment Sci 108: 704–707
Smigan L (1985) Long-term lithium treatment. Some clinical, psychological and biological aspects. Acta Psychiatr Scand 71: 160–170
Solomon DA, Bauer MS (1993) Continuation and maintenance pharmacotherapy for unipolar and bipolar mood disorders. Psychiatr Clin North Am 16: 515–540
Solomon DA, Keitner GI, Miller IW, Shea MT, Keller MB (1995) Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 56: 513
Solomon DA, Ristow WR, Keller MB, Kane JM, Gelenberg AJ, Rosenbaum JF, Warshaw MG (1996) Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am J Psychiatry 153: 1301–1307
Souza FGM, Goodwin GM (1991) Lithium treatment and prophylaxis in unipolar de-pression: a meta-analysis. Br J Psychiatry 158: 666–675
Stallone F, Shelley E, Mendlewicz J, Fieve RR (1973) The use of lithium in affective disorders. III. A double-blind study of prophylaxis in bipolar illness. Am J Psychiatry 130: 1006–1010
Stenstedt AC (1952) A study in manic-depressive psychosis. Acta Psychiatr Scand (suppl) 79: 1–111
Suppes T, Baldessarini RJ, Faedda GL, Tohen M (1991) Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 48: 1082–1088
Tondo L, Baldessarini RJ, Floris G, Rudas N (1997) Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders. Am J Psychiatry 154: 548–550
Tyrer SP, Shopsin B, Aronson M (1983) Dangers of reducing lithium. Br J Psychiatry 143: 427 (letter)
Waters B, Lapierre Y, Gagnon A, Cahudry R, Tremblay A, Sarantidis D, Gray R (1982) Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder. Biol. Psychiatry 17: 1323–1329
Zarate CA Jr, Tohen M, Banov M, Weiss MK, Cole JO (1995) Is clozapine a mood sta-bilizer? J Clin Psychiatry 56: 108–112
Zis AP, Goodwin FK (1979) Major affective disorders as a recurrent illness. Arch Gen Psychiatry 36: 835–839
Zis AP, Grof P, Goodwin FK (1979) The natural course of affective disorders: Implica-tions for lithium prophylaxis. In: Cooper TB, Gershon S, Kline NS, Schou M (eds) Lithium: controversies and unresolved issues. Excerpta Medica, Amsterdam, Oxford, Princeton, 381–398
Zis AP, Grof P, Webster MA, Goodwin FK (1980) Prediction of relapse in recurrent affective disorder. Psychopharmacol Bull 16: 47–49
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Greil, W., Kleindienst, N. (1997). Rezidivprophylaxe affektiver Störungen mit Lithium. In: Müller-Oerlinghausen, B., Berghöfer, A., Greil, W. (eds) Die Lithiumtherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60819-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-60819-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64570-9
Online ISBN: 978-3-642-60819-3
eBook Packages: Springer Book Archive